The treatment of breast carcinoma in situ

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

For last two decades frequency of revealing as minimal forms of a breast cancer, and carcinoma in situ considerably has increased. First of all it is connected to occurrence modern mammographic of engineering and introduction mammographic screening. However questions concerning optimum methods of treatment of a cancer in situ till now are not solved.

In the review the modern methods of the surgical and combined treatment of the given pathology are considered. The factors influencing risk of development of local relapses and metastasis at conserving treatment of a cancer in situ are in detail analyzed. The problems of a modern morphological classifications of disease are mentioned.

About the authors

V. V. Semiglazov

I. P. Pavlov State Medical University

Author for correspondence.
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg, 197022

References

  1. Ashikari R., Hajdu S. L, Robbins G. E Intraduc-tal carcinoma of the breast (1960-1969) // Cancer. 1971. Vol. 28. P. 1182-1187.
  2. Beahrs O.H, Henson D.E., Hutter R.V. Manual for staging of cancer. Ed. 4. Philadelphia: JB Lippincott. 1992. P 149-154.
  3. Bodian C. A., Perzin K. H, Lattes R. Lobular neoplasia: Long-term risk of breast cancer and relation to other factors // Cancer. 1996. Vol. 78. P 1024-1034.
  4. Carpenter R., Boulter P S., Cooke T., Gibbs N. M. Management of screen detected ductal carcinoma in situ of the female breast // Br. J. Surg. 1989. Vol. 76. P. 564-567.
  5. Davis R. P, Baird R. M. Breast cancer in association with lobular carcinoma in situ: clinicopathologic review and treatment recommendation // Am. J. Surg. 1984. Vol. 147. P. 641-645.
  6. Fisher B., Costantino J., Redmond C. et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer // N.Engl. L.Med. 1993. Vol. 328. P. 1581-1586.
  7. Fisher B., Dignam J., Wolmark N. et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from NSABP B-17 // J. Clin. Oncol. 1998. Vol. 16. P. 441-452.
  8. Fisher B., Dignam J., Wolmark N. et al. Tamoxifen in treatment of intraductal breast cancer: NSABP B-24 randomized controlled trial // Lancet. 1999. Vol. 3 5 3. P. 1993-2000.
  9. Fisher E.R., Dignam J., Tan-Chiu E., Costantino J. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of Protocol B-17 // Cancer. 1999. Vol. 86. № 3. P. 429-438.
  10. Fisher E. R., Sass R., Fisher B. et al. Pathologic findings from the NSABP (Protocol 6). II. Relation of local breast recurrence to multicentricity//Cancer. 1986. Vol. 57. P. 1717-1724.
  11. Frykberg E.R., Santiago E., Betsill W.L. et al. Lobular carcinoma in situ of the breast // Surg. Gynecol. Obstet. 1987. Vol. 164. P. 285-301.
  12. Goldstein N.,Vicini E., Kestin L., Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age // Cancer. 2000. Vol. 88. P. 2553-2560.
  13. Goodnight J.E., Quagliana J.M., Morton D.L. Failure of subcutaneous mastectomy to prevent the development of breast cancer // J. Surg. Oncol. 1984. Vol. 26. P. 198-201.
  14. Guidi A. J., Fischer L., Harris J.R., Schnitt S.J. Microvessel density and distribution in ductal carcinoma in situ of the breast // J. Natl. Cancer. Inst. 1994. Vol. 86. P. 614-619.
  15. Gump F. E., Jicha D. L., Ozello L. Ductal carcinoma in situ: A revised concept // Surgery. 1987. Vol. 102. P. 790-795.
  16. Haagensen C. D. Diseases of the breast. Ed. 3. Philadelphia:WB Saunders, 1986. P. 211.
  17. Hetelekidis S., Schnitt S.J., Morrow M., Harris J. R. Management od ductal carcinoma in situ // Cancer J. for Clinicians. 1995. Vol. 45. P. 244-253.
  18. Holland R. New aspects and pitfalls in the diagnosis of breast cancer // Thesis. Nijmegen. 1994. P. 79-109.
  19. Lagios M. D. Ductal carcinoma in situ: biological and therapeutic implications of classification // The Breast Journal. 1996. Vol. 2. № 2. P. 32-34.
  20. Lagios M. D. Ductal carcinoma in situ: biological implications for clinical practice // Seminars in Oncology. 1996. Vol. 23. № 1. P. 6-11.
  21. Lagios M. D. Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment // The Breast J. 1995. Vol. 1. № 2. P. 68-78.
  22. Lagios M. D. Heterogeneity of ductal carcinoma in situ: Relationship of grade and subtype analysis to local recurrence and risk of invasive transformation // Cancer Letters. 1995. Vol. 90. P. 97-102.
  23. Lagios M.D., Margolin F.R., Westdahl P.R., Rose M. R. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence // Cancer. 1989. Vol. 63. P. 618-624.
  24. Lagios M.D., Silverstein M.J. Ductal carcinoma in situ // Surgical Oncology Clinics of North America. 1997. Vol. 6. № 2. P. 385-392.
  25. Lagios M.D., Westdahl P.R., Margolin E.R. et al. Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentrcity, lymph node metastases, and short-term treatment failures // Cancer. 1982. Vol. 50. P. 1309-1314.
  26. Lattes R. Lobular neoplasia (lobular carcinoma in situ) of the breast- a histological entity of controversial clinical significance // Pathol Res Pract. 1980. Vol. 166. P. 415-429.
  27. Page D. L., Kidd T. E., Dupont W. D. et al. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease // Hum Pathol. 1991. Vol. 22. P. 1232-1239.
  28. Rosen P. P. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma // Cancer. 1980. Vol. 46. P. 1289-1306.
  29. Rosen P P Lobular carcinoma in situ and intraductal carcinoma of the breast // Monogr Pathol. 1984. Vol. 25. P. 59-105.
  30. Rosen P.P, Braun D.W., Lyngholm B. et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral masectomy and contralateral breast biopsy // Cancer. 1981. Vol. 47. P. 813-819.
  31. Rubio I., Mirza N., Sahin A. et al. Role of specimen radiograph in patient treated with skin-sparing mastectomy for ductal carcinoma in situ of
  32. the breast // ASCO. 2000. abstracts on CD-ROM. -abstract 346.
  33. Schwarts G.E, Solin L.J., Olivotto L.A., Erns-ter V. L. The consensus conference on the treatment of in situ ductal carcinoma of the breast. April 22-25, 1999 // The Breast Journal. 2000. Vol. 6. № 1. P. 4-13.
  34. Silverstein M. J. Lagios M. D. Use of predictors of recurrence to plan therapy for DCIS of the breast // Oncology. 1997. Vol. 11. № 3. P. 393-410.
  35. Silverstein M. J. Lagios M.D., Groshen S. et al. The influence of margin width on local control of ductal carcinoma in situ of the breast // N. Engl. J. Med. 1999. Vol. 340. № 19. P. 1455-1461.
  36. Silverstein M.J., Lagios M. D., Craig P. H. et al. A prognostic index for ductal carcinoma in situ of the breast // Cancer. 1996. Vol. 77. P. 1167-1174.
  37. Silverstein M.J., Poller D.N., Waisman J.R. et al. Prognostic classification of breast duct carcinoma in situ // Lancet. 1995. Vol. 345. P. 1154-1157.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.